Dna X (SONM) Accumulated Expenses (2018 - 2026)

Dna X has reported Accumulated Expenses for 9 years, with the latest figure at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 89.58% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 89.58% YoY), and the FY2025 full-year result was $704000.0, up 181.6% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $1.6 million, up from $704000.0 in the prior quarter.
• The five-year high for Accumulated Expenses was $23.1 million in Q3 2024, with the low at $250000.0 in Q4 2024.
• Historically, Accumulated Expenses has averaged $8.5 million across 5 years, with a median of $10.7 million in 2022.
• The largest YoY upside for Accumulated Expenses was 2276.8% in 2024 against a maximum downside of 97.97% in 2024.
• Dna X's Accumulated Expenses stood at $10.7 million in 2022, then climbed by 15.04% to $12.3 million in 2023, then plunged by 97.97% to $250000.0 in 2024, then soared by 181.6% to $704000.0 in 2025, then surged by 123.86% to $1.6 million in 2026.
• The last three Accumulated Expenses figures came in at $1.6 million (Q1 2026), $704000.0 (Q4 2025), and $13.6 million (Q3 2025), per Business Quant data.